Torrent Pharmaceuticals Limited
TORNTPHARM
Κατάταξη σε μετοχές
#1198
Torrent Pharmaceuticals Limited operates as a global pharmaceutical entity,... Torrent Pharmaceuticals Limited operates as a global pharmaceutical entity, managing the entire process from the discovery and development of generic drug formulations to their production and distribution. Its commercial activities extend across key markets such as India, the United States, Germany, and Brazil, alongside various other international territories. The company boasts a broad product catalog, offering treatments for a wide array of medical conditions. This includes therapies for cardiovascular diseases, central nervous system disorders, gastrointestinal issues, women's health concerns, diabetes, pain management, gynecological ailments, oncology, and anti-infective medications. Additionally, Torrent Pharma supplies essential vitamins, minerals, and other nutritional supplements. Beyond its proprietary offerings, the firm also provides contract manufacturing services to other companies. During the COVID-19 pandemic, it demonstrated its commitment by securing licensing agreements for crucial treatments like Baricitinib, Molnupiravir, and Paxlovid. Established in 1959, the company originally operated under the name Trinity Laboratories before officially becoming Torrent Pharmaceuticals Limited in 1971. Its corporate headquarters are located in Ahmedabad, India. Ultimately, Torrent Pharmaceuticals Limited functions as a subsidiary of Torrent Investments Private Limited.
Τιμή μετοχής
$50.34
Τελευταίος συγχρονισμός: 2026-10-19
Κεφαλαιοποίηση
$19.15B
Αλλαγή (1 ημέρα)
-0.07%
Αλλαγή (1 έτος)
23.92%
Χώρα
IN
Εμπόριο Torrent Pharmaceuticals Limited (TORNTPHARM)
Κατηγορία
Healthcare
EPS για Torrent Pharmaceuticals Limited (TORNTPHARM)
EPS στις June 2026 TTM: $0.71
Σύμφωνα με τις τελευταίες οικονομικές αναφορές και την τιμή της μετοχής της Torrent Pharmaceuticals Limited, το τρέχον EPS της εταιρείας (TTM) είναι $0.71. Στο τέλος του 2024, η εταιρεία είχε EPS $0.59, αύξηση σε σχέση με το EPS του 2023 που ήταν $0.45.
Ιστορικό EPS της Torrent Pharmaceuticals Limited από 2005 έως 2026
EPS στο τέλος κάθε έτους
| Έτος | EPS | Αλλαγή |
|---|---|---|
| 2026 (TTM) | $0.71 | 7.76% |
| 2025 | $0.66 | 12.51% |
| 2024 | $0.59 | 31.09% |
| 2023 | $0.45 | 48.00% |
| 2022 | $0.30 | -40.13% |
| 2021 | $0.51 | 25.73% |
| 2020 | $0.40 | 116.54% |
| 2019 | $0.19 | -39.70% |
| 2018 | $0.31 | -27.64% |
| 2017 | $0.43 | -44.97% |
| 2016 | $0.77 | 117.38% |
| 2015 | $0.36 | 8.68% |
| 2014 | $0.33 | 39.00% |
| 2013 | $0.24 | 42.24% |
| 2012 | $0.17 | -7.59% |
| 2011 | $0.18 | 17.75% |
| 2010 | $0.15 | 41.62% |
| 2009 | $0.11 | 7.94% |
| 2008 | $0.10 | 56.20% |
| 2007 | $0.06 | 89.02% |
| 2006 | $0.03 | 2.12% |
| 2005 | $0.03 | 0.00% |
EPS για παρόμοιες εταιρείες ή ανταγωνιστές
| Εταιρεία | EPS | Διαφορά EPS | Χώρα |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| $0.56 | -21.78% |
IN
|
